Venture Capitalists Remain Bullish On Cardiovascular Technology
This article was originally published in The Gray Sheet
Executive Summary
Cardiovascular devices will remain an attractive target for venture capital investments for the foreseeable future, according to a recent expert panel on venture investing in cardiovascular technology